Upper Respiratory InfectionNCT00187785
Doctor-Patient Communication in Spanish
A study testing Spanish speaker level in people with Upper Respiratory Infection and Hypertension, run by University of California, San Francisco at 1 site in United States.
Trial summary
Does use of a translator or use of less than perfect Spanish diminish provider-patient communication compared to a native speaker. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Upper Respiratory Infection, Hypertension, Diabetes
- What is being tested?
- Spanish speaker level
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- Sep 2005to Dec 2006
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Spanish speaker
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
About this study
Does use of a translator or use of less than perfect Spanish diminish provider-patient communication compared to a native speaker.
Read the detailed description
Spanish speaking drop-in patients will be consented then randomized to receive care by a native Spanish speaker, an English speaker using a translator, or an English speaker with intermediate Spanish skills using Spanish. After the visit, the researcher will enquire about patient satisfaction, when the next appointment is, whether medication has been changed, and what instructions their provider gave them. Each provider will do a similar questionnaire. A blinded researcher will score a concordance of plans between provider and patient to see if there is a significant difference in retained information between the groups.
- Conditions
- Upper Respiratory Infection, Hypertension, Diabetes
- Being tested
- Spanish speaker level
- Keywords
- Hispanic, communication
- Medical subject headings
- Respiratory Tract Infections, Hypertension, Diabetes Mellitus, Communication
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Spanish speaker levelBehavioural
What is being measured
The primary outcome is the main question the study is designed to answer.
retention of medical information
Secondary outcomes (1)
patient satisfaction
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2005 (estimated)
- Study startSep 2005
- Study completionDec 2006
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Upper Respiratory InfectionStudies of the same condition, open and under way.
- More trials run by University of California, San FranciscoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Early clinical test
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 100 participants
Sponsor and investigators
- Lead sponsor
- University of California, San Francisco
- Sponsor type
- University, hospital or other
- Investigators
- Roger B Mortimer, MD, Principal investigator, Department of Family Practice
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00187785
- Sponsor's protocol ID
- UMC200552
- Status last verified
- Aug 2005
- First submitted
- 14 Sep 2005
- Last updated
- 18 Jan 2006
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Jan 2006. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Doctor-Patient Communication in Spanish
- ClinicalTrials.gov ID
- NCT00187785
- Acronym / sponsor ID
- UMC200552
- Conditions
- Upper Respiratory Infection, Hypertension, Diabetes
- Keywords
- Hispanic, communication
- Study type
- Interventional
- Recruitment status
- Terminated
- Enrolment
- 100 participants
- Lead sponsor
- University of California, San FranciscoUniversity, hospital or other
- Study start
- Sep 2005
- Study completion
- Dec 2006
- First posted
- 16 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Does use of a translator or use of less than perfect Spanish diminish provider-patient communication compared to a native speaker.
Detailed description
Spanish speaking drop-in patients will be consented then randomized to receive care by a native Spanish speaker, an English speaker using a translator, or an English speaker with intermediate Spanish skills using Spanish. After the visit, the researcher will enquire about patient satisfaction, when the next appointment is, whether medication has been changed, and what instructions their provider gave them. Each provider will do a similar questionnaire. A blinded researcher will score a concordance of plans between provider and patient to see if there is a significant difference in retained information between the groups.
Study design
- Primary purpose
- Early clinical test
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Spanish speaker
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Spanish speaker level | Behavioural | – |
Primary outcome
retention of medical information
1 secondary outcome
patient satisfaction
Results and safety
The study was stopped early. Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jan 2006.
Related trials for Upper Respiratory Infection
Not yet recruitingPhase 4
SPARK Study - Sympathetic Periarterial Radial Block in Healthy Volunteers
Healthy Volunteers, Sympathetic Activity
Not yet recruiting
Influence of Patient Positioning During Nasal Lavage
Acute Upper Respiratory Tract Infections, Nasal Obstruction
Recruiting
Safety and Efficacy of NTP in Thyroid Surgery: Pilot Study on Morbidity Prevention and Adjuvant Oncological Control
Thyroid Diseases, Wound Healing
RecruitingObservational study
A Study to Evaluate Treating Watery Noses With Cryotherapy in the Clinic Setting. This is Cold Therapy, Freezing the Issues at the Back of the Nose to Ease Symptoms.
Chronic Rhinitis
Not yet recruiting
Evaluating Sucrose and Cold Oral Interventions for the Treatment of Oral Pruritus During Allergy Procedures.
Allergy, Food Allergies
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Roger B Mortimer, MD principal investigator
Department of Family Practice
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Spanish speaker level in people with Upper Respiratory Infection and Hypertension, run by University of California, San Francisco at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 18 Jan 2006. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early. Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
retention of medical information. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2006.